Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,059,412
-
Total 13F shares
-
17,818,092
-
Share change
-
-126,371
-
Total reported value
-
$83,924,627
-
Price per share
-
$4.71
-
Number of holders
-
59
-
Value change
-
-$799,192
-
Number of buys
-
19
-
Number of sells
-
32
Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2020
As of 30 Sep 2020,
Apyx Medical Corp - Common Stock (APYX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,818,092 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Archon Capital Management LLC, BlackRock Inc., VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Taylor Frigon Capital Management LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.